XML 31 R8.htm IDEA: XBRL DOCUMENT
v2.4.0.6

BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING PRO-NOUNCEMENTS | 9 Months Ended
--- | ---
Sep. 30, 2012
Basis Of Presentation And Recently Issued Accounting Pro-Nouncements |
BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS | NOTE 2 – BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Interim Financial Statements The accompanying unaudited interim condensed consolidated financial statements of Therapeutics have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles ("GAAP”) for complete financial statements. In the opinion of management, such financial statements include all adjustments (consisting solely of normal recurring adjustments) necessary for the fair statement of the financial information included herein in accordance with GAAP and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The balance sheet at December 31, 2011 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. Results of operations for interim periods are not necessarily indicative of results for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2011. Recently Issued and Newly Adopted Accounting Pronouncements The Company does not expect that the adoption of any recent accounting pronouncements will have a material impact on its condensed consolidated financial statements.

X
- Details
Name: | txmd_BasisOfPresentationAndRecentlyIssuedAccountingPronouncementsAbstract
Namespace Prefix: | txmd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the basis of presentation, used to prepare the financial statements and recently issued accounting pronouncements including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items. + References No definition available. + Details
Name: | txmd_BasisOfPresentationAndRecentlyIssuedAccountingPronouncementsTextBlock
Namespace Prefix: | txmd_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration